285 related articles for article (PubMed ID: 21874264)
1. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
[TBL] [Abstract][Full Text] [Related]
2. Identification of aberrantly expressed miRNAs in rectal cancer.
Li X; Zhang G; Luo F; Ruan J; Huang D; Feng D; Xiao D; Zeng Z; Chen X; Wu W
Oncol Rep; 2012 Jul; 28(1):77-84. PubMed ID: 22576798
[TBL] [Abstract][Full Text] [Related]
3. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression.
Tchernitsa O; Kasajima A; Schäfer R; Kuban RJ; Ungethüm U; Györffy B; Neumann U; Simon E; Weichert W; Ebert MP; Röcken C
J Pathol; 2010 Nov; 222(3):310-9. PubMed ID: 20726036
[TBL] [Abstract][Full Text] [Related]
4. microRNA expression profile in undifferentiated gastric cancer.
Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of miR-10b expression in gastric carcinoma.
Wang YY; Ye ZY; Zhao ZS; Li L; Wang YX; Tao HQ; Wang HJ; He XJ
Hum Pathol; 2013 Jul; 44(7):1278-85. PubMed ID: 23351547
[TBL] [Abstract][Full Text] [Related]
6. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
8. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression.
Sun Q; Gu H; Zeng Y; Xia Y; Wang Y; Jing Y; Yang L; Wang B
Cancer Sci; 2010 Oct; 101(10):2241-7. PubMed ID: 20666778
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of microRNA-143 and -145 in human gastric cancers.
Takagi T; Iio A; Nakagawa Y; Naoe T; Tanigawa N; Akao Y
Oncology; 2009; 77(1):12-21. PubMed ID: 19439999
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
Wang LP; Ma XQ; Cai JC
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3269-73. PubMed ID: 23328512
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
13. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
14. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.
Cui L; Zhang X; Ye G; Zheng T; Song H; Deng H; Xiao B; Xia T; Yu X; Le Y; Guo J
Cancer; 2013 May; 119(9):1618-26. PubMed ID: 23335180
[TBL] [Abstract][Full Text] [Related]
15. Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
[TBL] [Abstract][Full Text] [Related]
16. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
[TBL] [Abstract][Full Text] [Related]
17. miR-21 microRNA expression in human gastric carcinomas and its clinical association.
Chan SH; Wu CW; Li AF; Chi CW; Lin WC
Anticancer Res; 2008; 28(2A):907-11. PubMed ID: 18507035
[TBL] [Abstract][Full Text] [Related]
18. miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
Sun T; Wang C; Xing J; Wu D
Eur J Cancer; 2011 Nov; 47(17):2552-9. PubMed ID: 21684154
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
